HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Bartley AN, Washington MK, Ventura CB, Ismaila N, Colasacco C, Benson AB, Carrato A, Gulley ML, Jain D, Kakar S, Mackay HJ, Streutker C, Tang L, Troxell M, Ajani JA
Arch Pathol Lab Med. 2016 140 (12): 1345-1363

PMID: 27841667 · DOI:10.5858/arpa.2016-0331-CP

MeSH Terms (20)

Adenocarcinoma Biomarkers, Tumor Clinical Decision-Making Combined Modality Therapy Decision Trees Diagnosis, Differential Esophageal Neoplasms Evidence-Based Medicine Humans Medical Oncology Molecular Diagnostic Techniques Molecular Targeted Therapy Mutation Neoplasm Grading Neoplasm Staging Pathology, Clinical Receptor, ErbB-2 Societies, Medical Stomach Neoplasms United States

Connections (1)

This publication is referenced by other Labnodes entities: